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ABSTRACT:
Introduction:  General practitioners (GPs) participate in a patient’s cancer care to different extents at different times,
from prevention and diagnosis to treatment and end-of-life care. Traditionally, the GP has had a minor role in cancer
treatment.  However,  oncological  and surgical  services frequently  delegate  limited  cancer  treatment  tasks  to  GPs,
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especially in rural areas far from hospitals. The aim of this study was to explore the extent of GPs’ participation in
cancer treatment in Norway.
Methods:  This study was an observational questionnaire study. In 2007, the chief municipal medical officer in all
93 municipalities in North Norway and a 25% random sample (85 municipalities) in South Norway was asked to identify
up  to  five  GPs  who  had  recently  participated  in  local  treatment  of  cancer  patients,  and  to  forward  a  patient
questionnaire to them.
Results:  Seventy-eight GPs in 49 municipalities returned completed questionnaires for 118 patients, most of them with
progressive disease and living in rural areas. All the GPs reported substantial participation in therapeutic tasks for this
select group of patients. Not counting palliative treatment,  64% of the GPs participated in cancer treatment either
directly,  or  indirectly  through  referrals.  Twenty  patients  received  chemotherapy;  they  belonged  to  no  particular
diagnostic category. Eighty-eight percent of the GPs prescribed some kind of palliative medicine, such as analgesic,
antiemetic,  anxiolytic  or  antidepressant.  Morphine was prescribed equally  often by GPs and hospitals.  Eighty-one
percent  of  GPs  reported  having  had  a  thorough  conversation  with  the  patient  about  the  patient’s  condition  and
circumstances.
Conclusion:  In this group of GPs, participation rates were high for most of the therapeutic and communicative tasks
suggested in the questionnaire. GP participation is feasible not only in palliative care, but also in some aspects of
oncological treatment and in clinical follow-up. Communication with both patient and hospital seemed good in this local
setting. GPs are important helpers for some cancer patients.
KEYWORDS:
cancer, continuity of patient care, family practice, general practice, Norway, palliative care, patient care, primary health
care.
FULL ARTICLE:
Introduction
For a patient living through cancer, the participation of their general practitioner (GP) in care varies during the disease’s
course .  The  GP  has  an  important  role  in  understanding  and  exploring  symptoms  to  distinguish  cancer  from
non-cancer  and in palliative care at the end of life . Traditionally, hospital doctors perform the treatment of cancer.
However, especially in rural and remote areas, some treatment has been decentralised to GP surgeries and rural
hospitals . Many patients want their GP to take an active part in the cancer therapy . Also, GPs have an important role
in psychosocial care and care for side effects of treatment . Supporting patient and family, translating information
into lay language and being a mediator between patient and specialist care are also important GP tasks . In areas
with long distances to hospital, patients could save travel time if GPs performed more tasks .
The interface between secondary and primary care has long been recognised as a critical point regarding quality of
care . Communication between lines of health care is often found wanting . Especially important when sharing care is
timeliness of specialists’ communications to GPs . In addition to questions arising during the active phase of cancer
treatment, GPs deal with an increasing number of survivors who need assistance based on a profound understanding
of cancer sequelae and of possible complications of treatment . Given their often long-lasting and close relationships
with their patients, GPs are in a position to accompany them throughout the whole process of cancer care . However,
such longitudinal involvement has been relatively uncommon .
The aim of this study was to explore how Norwegian GPs participated in different kinds of cancer treatment, and for
what forms of cancer. Furthermore, the authors asked what kind of communication the GPs had with patients and
hospital doctors, as well as with local health personnel and patients’ relatives. Finally, the authors wanted to discuss
what is feasible and appropriate.
Methods
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The chief municipal medical officer in 178 Norwegian municipalities in April 2007 received an invitation letter together
with  enclosed  letters  to  GPs  containing  self-explanatory  four-page  questionnaires  (Appendix  I),  modified  from  a
previous study . The medical chief was asked to identify up to five GPs who might have participated in local treatment
of cancer patients in 2006–07 and to forward the questionnaire to them. Thus, the intention was to recruit a rather
select group of GPs who had experience from work with cancer patients. All 93 municipalities in North Norway and a
25% random sample (85 municipalities) in South Norway received the invitation. Treatment intention could have been
curative or palliative. The anonymous patient could be alive or dead at the time of reporting. In addition to marking
pre-defined answers, the GPs were encouraged to give free-text commentaries.
Participating GPs received no remuneration, only a certificate attesting the approximate time they had spent answering
the questionnaire. In Norway, such participation in research contributes a limited number of points for the compulsory
recertification of GP specialty every fifth year.
Statistics
Chi-square analysis and Mann–Whitney U-test were used to examine differences between groups. Significance level
was p<0.05.
Ethics approval
The survey protocol was accepted by the Data Inspectorate of Norway (Project 12962) and ethical approval for the
project was given by the Regional Committee for Medical and Health Research Ethics of Northern Norway (P REK
Nord 44/2005). Only the individual GP knew the identity of any single patient.
Results
Seventy-eight GPs from 49 (28% of invited) municipalities returned completed questionnaires for 118 patients. The GPs
were 36% women and 64% men with an average age of 47 years and an average GP experience of 16 years. Mean
age and sex distribution were very close to those of all Norwegian GPs . There was no difference in participation
between north and south. There was a non-significant tendency that GPs in the south had worked a little longer in
general practice then GPs in the north – median 20 years and 14.5 years, respectively. Only six of the municipalities
were towns with more than 20 000 inhabitants, which means that the majority of patients lived in rural communities or
small towns quite far away from hospitals. However, a few localities had rural hospitals , and most other places had
rooms reserved for terminal or other temporary patients in the local nursing home.
The 118 patients comprised 59 women and 59 men. Overall mean and median age was 63 years, median age for
women was 61 years and for men 63 years. One patient was a child, and the oldest patient was aged 89 years.
Table 1 shows cancer diagnosis by site, with digestive organs as the major localisation of cancer. All major forms of
cancer were represented. Sixty percent of the patients were alive at the time of registration, 16% were in the terminal
stage and 12% were in a good condition without ongoing treatment. For 20% of the patients the intention of treatment
was curative and the GPs reported that life expectancy at the beginning of treatment was more than 6 months for 63%
of the patients. One-third of the patients waited more than 4 weeks before treatment started. The clinical status had
been declining for 80% of the patients.
Table 2 shows how the GPs participated in drug and adjuvant treatment of cancer patients. Not counting palliative
treatment, 64% of the GPs participated either directly, or indirectly through referrals, in cancer treatment. Seventeen
percent of all the GPs participated in administration of chemotherapy, while more than half of the GPs referred patients
to other investigations or treatment. The 20 patients who received chemotherapy belonged to no particular diagnostic
category, nor were there sex or age differences. Eighty-eight percent of the GPs prescribed some kind of palliative
medicine to the patients, especially analgesic and antiemetic drugs. Anxiolytic or antidepressive drugs were prescribed
to  about  half  of  the  patients.  Morphine  was  prescribed  equally  often  from  GPs  as  from  hospital.  Alternative  or
complementary medicine was discussed infrequently. Two-thirds of the GPs treated their patients for complications of
cancer treatment, with advice from the hospital in 70% of the cases. GPs were involved in the treatment of worsening
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or relapse for 74% of the patients, most often in cooperation with hospital doctors. For treatment of other disease after
cancer was diagnosed, the GPs had contact with the hospital in 41% of the cases. GPs treated patients in several
locations, and 59% had some treatment at home. One-third of the GPs reported responsibility for coordinating home
care, and two-thirds contributed to different kinds of administrative help.
Table 3 gives an overview of the communication between GP and patient, and of cooperation with the hospital. Almost
one-third of the GPs contributed to informing the patient about their diagnosis, and 81% reported having had a thorough
conversation  with  the  patient  about  the  patient’s  condition  and  circumstances.  Other  health  professionals  and
family/friends were important in the care of most patients. In this local setting, a high proportion of the GPs reported that
they had had written and/or oral communication with hospital doctors. During the terminal stage most patients were
treated at home or at a nursing home; of the patients who died, less than half died at home. The GPs had contact with
the family in 72% of the cases after a patient died.
Table 1: Patient characteristics and cancer diagnoses by anatomical site (n=118)
Table 2: General practitioner participation in drug and adjuvant treatment of cancer patients (n=118)
Table 3: Communication between general practitioner and patient, and cooperation with hospital (n=118)
Discussion
Main findings
The study demonstrates that some rural and small-town GPs contributed considerably to cancer care in their patients’
local communities. Most of the patients reported here had progressive disease. Thus, not only the GPs, but also the
patients, belonged to a rather select group of cancer patients with a higher than usual need for GPs’ services. For this
group, GP participation was substantial not only in palliative care, but also in some aspects of oncological treatment
and in clinical follow-up. Most patients received morphine or other analgesic drugs, and the GP had the possibility of
both monitoring day-to-day needs and providing prescriptions. The contact with specialist services seemed to be good
and useful in most cases. Chemotherapy should and would not be initiated by a Norwegian GP without an initiative and
a treatment  protocol  from an oncologist.  Initiation of  palliative treatment  as  well  as  treatment  of  complications or
disease progression would regularly be discussed with a hospital specialist before the GP acts. After such treatment
has been initiated, the GP is more free to adjust dosages.
We may assume that the patient work and the contact with specialists contributed to gradually increased knowledge
and skills regarding cancer. Some free-text comments from the GPs supported this. From the GPs’ viewpoint,  the
communication with the patient also seemed good in this local setting, and there was contact with the family in the
majority of cases, both before and after a patient had died. The authors do not have data about the experiences of
patients or family carers. However, offering cancer treatment locally is based on an agreement between the patient, the
hospital and the local clinicians; the GP and the community nurse, often also an oncology nurse. With local treatment,
patients avoid strenuous travelling and might stay in closer contact with their family. The close contact with their local
GP and nurses can be a bonus, too.
Less than half of the patients died at home. In recent years, palliative beds in local aged care facilities or in small
community  hospitals  have  become common places  to  transfer  a  terminally  ill  patient  when  treatment  at  home
becomes difficult. These palliative units aim for sustained contact between patient and family and continuity of care by
local GPs and nurses.
Discussion within the context of the literature
Within the treatment time sequence, GPs may seem to have no role as long as the primary cancer treatment is going
on. However, some treatments go on for months, and most patients would appreciate coming home and receiving some
of the treatment locally. Pathmanathan et al  found it safe to administer chemotherapy regimens to rural patients,
without increased morbidity or mortality. In rural areas of Australia, GPs have also administered chemotherapy, and the
likelihood of this increased with remoteness . This has also been shown in the northernmost,  sparsely populated
country of Norway . In the present study, the GPs reported no problems related to chemotherapy administration in 20
patients living far from hospital services. However, shared care with good communication between primary care and
hospitals is necessary in these cases and seems to have been practised. Detailed and timely communication with
specialists, particularly about treatment regimens and follow-up care, is often emphasised when GPs are asked how
they can contribute to ensure optimal patient outcomes . A Canadian study  has shown that women caregivers in
rural areas experience considerable challenges in relation to patients with advanced cancer, and that preservation of
hope is a crucial factor.
Cancer care may demand quite intensive patient contact over an undetermined time period, and most GPs in one study
wanted to limit such a workload to the cases they actually dealt with . Patients emphasise the GP’s continuity of care
and good information that is patient-centred and holistic . After treatment, their main concern is recurrent disease, and
they may doubt that their GP has sufficient expertise to conduct follow-up . Two recent studies from Estonia and
France showed that most patients preferred to discuss their cancer-related problems with oncologists, but that patients
also  contacted  their  GPs  during  cancer  care,  in  France  often  during  the  initial  therapeutic  phase  of
cancer . Geographical questions were not raised in these studies. Altogether, these studies seem to reflect the
patients’  well-founded beliefs  that  a specialist  knows more about  cancer  than a GP, and that  a worsening of  the
condition may be discovered and treated more quickly and appropriately in the hospital. Patients without a trusting
relationship with their GPs might doubt their ability to discover and react appropriately to symptoms and signs indicative
of cancer. However, for important forms of cancer such as breast cancer and colon cancer, studies have shown that
shared care between hospital and GP is acceptable to patients and GPs , and guidelines increasingly recommend
delegation of specified follow-up elements to GPs. Close contact with a GP during and after cancer treatment could
give good possibilities of discussing personal preferences and therapeutic options.  
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After the primary treatment has been terminated, studies have suggested that, for most patients, GPs temporarily are
less important. Two randomised studies found no effect on quality of life of increased involvement of the GP during this
phase . It is possible that many patients need to feel they are regaining health and want to minimise contact with
health services beyond regular controls, most often offered in hospital. This does not mean that the GP is superfluous
at this time. Patients may still need the GP for other ailments. For cancer, shared care already from the time of initial
treatment is appreciated by patients  and becomes important with time . Often,  survivorship poses new medical
problems where the GP becomes increasingly important , and GPs can contribute to detection of recurrences . To
some extent, re-establishment of the contact between patient and GP can be helped by a proactive attitude of the
GP . A model for pro-active cancer care in primary care has been tested in the UK, helping to structure consultations
and cover  psychosocial  areas .  The present  study seems to  testify  that  the need for  contact  with  a  GP usually
increases if the cancer progresses and the patient approaches end-of-life care. The GP then gets important challenges
concerning skills, patient–doctor communication and collaboration with other health personnel .
Strength and limitations of findings
It may be considered as a major limitation that several years have passed since the answers were collected. The article
is the last in a series of four articles in a study entitled ‘Optimization of cancer diagnosis and treatment in family
practice’, and it has taken time to analyse and write the articles. Previous articles have dealt mainly with the diagnosis
part . However, geographical conditions have not changed in Norway, and the authors do not think the practice
described has changed much since data was collected. It may be seen as an advantage that findings can now be
discussed on the background of several recent publications.
Both patients and GPs are special in this study. Patients generally belonged to the unfortunate group with progressive
disease, and most of them lived in rural communities or small towns. They belong to a group of patients who have a
greater than usual need for GP services. This article presents ideas about how to deal with such patients, allowing
them to remain as much as possible in their home and local environment. Only a minority of GPs in each municipality
were expected to have been active in recent local cancer care. The local chief medical officer was therefore asked to
help select GPs who had been involved in such care, and to send them a request to participate in this study. This may
be considered a strength of the study if it means that these GPs were devoted to their tasks and thus gave examples of
dedicated care. It is not known to what extent these GPs had previous experience with cancer treatment. However,
because  most  of  them worked  in  remote  areas  with  access  to  rural  hospital  beds,  this  is  probable  for  many of
them. Most doctors also had long experience as GPs. Because this study aimed for answers from GPs who had
practical experience with cancer treatment, the low response rate is less important.
The information was collected retrospectively in a questionnaire, mainly with pre-selected categories where recall may
be imperfect and answers may not fit in the categories offered. However, cancer patients in poor condition are not
frequent in a GP practice and are often well remembered by the GP. GPs probably also consulted their medical record
notes when completing the questionnaires, as suggested in the letter to the GPs in Appendix I. Free-text comments did
not suggest difficulties in reporting. Altogether, the findings gave a coherent picture of dedicated GPs working with very
ill patients staying close to their home. In retrospect, it would have been interesting to know more about how the GPs
cooperated locally with other health professionals, such as cancer nurses and community nurses.  
Conclusion
This study contributes a description of many types of cancer care performed in general practice, in patients with quite
advanced disease. Through this, it also contributes an increased understanding of what is feasible and appropriate GP
work for  such patients.  In this select  group of  GPs,  participation rates were high for  most of  the therapeutic and
communicative tasks suggested in the questionnaire, and there was an obvious need for such services. In spite of
some understandable skepticism on the part of patients, studies have shown that a close contact with a local GP during
and after cancer treatment may be beneficial from many points of view. The optimal way to organise cancer care may
vary in  different  kinds of  communities,  and more  research about  this,  and about  the  GP’s  role,  is  pertinent.  The
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closeness of the GP to the patient probably was important when a patient’s clinical condition changed. Challenges may
be most complex but at the same time most interesting in communities far from hospitals.
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